AstronauTx and STORM recognised at inaugural One Nucleus Awards
Congratulations to our clients AstronauTx and STORM Therapeutics, which were recognised at the inaugural One Nucleus Awards in London in March.
AstronauTx scooped the Best Performing Primary R&D Company of the Year Award, while STORM won the One Nucleus Boston Bootcamp competition aimed at getting companies “US-ready”.
AstronauTx beat off strong competition to win the award, which recognises companies investing their own capital in R&D to develop new products and technologies to improve patient outcomes.
The company won out in the category that was judged against a stringent set of criteria designed to highlight stellar performance in biotech research.
Criteria included level of innovation, investment raised and impact, and R&D deals signed. It also focused on patient engagement, growth including talent development and culture, effective environmental, social and governance strategy, and media recognition.
Optimum Strategic Communications played an instrumental role in the launch of AstranauTx with its Series A financing of £48 million ($61 million) to create new treatments for Alzheimer’s disease.
The proceeds of the Series A financing will be used to advance the company’s portfolio of small-molecule drugs, including a clinical study in patients with Alzheimer’s disease for the lead programme. The treatments are expected to provide both symptomatic and disease modifying benefits.
Causing a STORM at the Boston Bootcamp
Another success was STORM Therapeutics, winner of the One Nucleus Boston Bootcamp, aimed at getting biotechs ready for the U.S.
The competition attracted a diverse range of entries from across the UK that showcased the breadth of innovation in R&D drug discovery and platform technologies in the country.
STORM was one of four companies that embarked on a journey to the world class Life Science Hub Boston, where they connected with key U.S. contacts and gained valuable insights navigating the Massachusetts life sciences ecosystem.
Boston is recognised as one of the productive and influential areas for life sciences innovation in the world, and the companies taking part were able to learn about operational strategies, raising investment and striking R&D collaborations.
There was also a series of preparatory sessions to help competition winners focus on their needs and knowledge gaps.
Optimum’s Zoe Bolt was also on hand to present the best Professional Services Company award, which Optimum was pleased to sponsor at the inaugural ceremony.
Mary Clark, CEO of Optimum Strategic Communications, said:
“It’s amazing to see our clients rewarded for their hard work and dedication to improving outcomes for patients. The therapies they are developing have the potential to make a real difference to peoples’ lives and I am thrilled that they have been recognised at this prestigious inaugural awards ceremony.
It was a great evening to be involved in and I am sure the connections built there will help the UK’s burgeoning life sciences industry go from strength to strength. The awards ceremony showcased the importance of communication and how having a compelling story and messaging strategy can reap dividends, by boosting awareness about the vital research conducted by UK biotechs.”
